Tag Archives: in part because of stringent antitrust rules antitrust

false advertising claim fails, in part because of stringent antitrust rules

In re EpiPen (Epinephrine Injection, USP) Marketing, Sales Practices & Antitrust Litig., MDL No. 2785, No. 17-md-2785-DDC-TJJ (D. Kan. Dec. 17, 2020) A lot of stuff here; I will ignore the non-false advertising related aspects of this mostly antitrust case. … Continue reading

Posted in Uncategorized | Tagged , , | Leave a comment